Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend/template update to the Study Details page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the template or formatting rather than changes to the study details.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, indicating a small underlying update to the page. This change does not alter visible content or user-facing functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedNew guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now indicates no participants are being sought. The Intervention/Treatment heading was updated and the revision tag bumped from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check69 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a small update to the page metadata; no study data or eligibility criteria are affected.SummaryDifference0.0%

- Check91 days agoChange DetectedA new 'Sample Collection' item was added and the page revision updated to v3.5.4; the previous version v3.5.3 was removed.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.